Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Interest Coverage Ratio (2018 - 2025)

X4 Pharmaceuticals' Interest Coverage Ratio history spans 8 years, with the latest figure at 10.84 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 30.06% year-over-year to 10.84; the TTM value through Dec 2025 reached 9.79, down 135.78%, while the annual FY2025 figure was 9.79, 135.78% down from the prior year.
  • Interest Coverage Ratio reached 10.84 in Q4 2025 per XFOR's latest filing, up from 12.19 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 32.68 in Q2 2024 to a low of 31.41 in Q4 2021.
  • Average Interest Coverage Ratio over 5 years is 15.81, with a median of 19.85 recorded in 2022.
  • Peak YoY movement for Interest Coverage Ratio: surged 245.37% in 2024, then tumbled 135.97% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 31.41 in 2021, then grew by 28.82% to 22.36 in 2022, then surged by 40.24% to 13.36 in 2023, then decreased by 16.02% to 15.5 in 2024, then skyrocketed by 30.06% to 10.84 in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Interest Coverage Ratio are 10.84 (Q4 2025), 12.19 (Q3 2025), and 11.75 (Q2 2025).